Neurological soft signs and brainstem morphology in first-episode schizophrenia

Neuropsychobiology

Volumn 68, Issue 2, 2013, Pages 91-99

  Hirjak, Dusan ^a   Wolf, Robert Christian ^a   Stieltjes, Bram ^b   Hauser, Thomas ^c   Seidl, Ulrich ^d   Thiemann, Ulf ^a   Schröder, Johannes ^a   Thomann, Philipp Arthur ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Department of Radiology   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d KLINIKUM STUTTGART   (Germany)

Author keywords

Brainstem; Magnetic resonance imaging; Neurological soft signs; Schizophrenia

Indexed keywords

ADULT; ARTICLE; BRAIN SIZE; BRAIN STEM; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FIRST EPISODE SCHIZOPHRENIA; HUMAN; MALE; MESENCEPHALON; MORPHOMETRICS; NEUROLOGIC DISEASE; NEUROLOGICAL SOFT SIGN; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PONS; PRIORITY JOURNAL; SCHIZOPHRENIA; CAUCASIAN; DSM-IV; HEIDELBERG SCALE; MEDULLA OBLONGATA; MENTAL PATIENT; MOTOR COORDINATION; NEUROIMAGING; NEUROLOGIC DISEASE ASSESSMENT; NUCLEAR MAGNETIC RESONANCE SCANNER; RIGHT HANDEDNESS; SPATIAL ORIENTATION; TREATMENT DURATION; YOUNG ADULT;

ADULT; BRAIN STEM; DIAGNOSTIC TECHNIQUES, NEUROLOGICAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; NEUROIMAGING; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

ARIPIPRAZOLE; CHLORPROMAZINE; CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE;

EID: 84880287996     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000350999     Document Type: Article

References (72)

1. Buchanan RW, Heinrichs DW: The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res 1989; 27:335-350.
2. Chan RC, et al: Neurological soft signs in non-psychotic first-degree relatives of patients with schizophrenia: a systematic review and meta-analysis. Neurosci Biobehav Rev 2010; 34:889-896.
3. Chan RC, et al: Neurological soft signs in schizophrenia: a meta-analysis. Schizophr Bull 2010; 36:1089-1104.
4. Chan RC, Gottesman II: Neurological soft signs as candidate endophenotypes for schizophrenia: a shooting star or a Northern star? Neurosci Biobehav Rev 2008; 32:957-971.
5. Walther S, Strik W: Motor symptoms and schizophrenia. Neuropsychobiology 2012; 66: 77-92.
6. Jahn T, et al: Motoric neurological soft signs and psychopathological symptoms in schizophrenic psychoses. Psychiatry Res 2006; 142: 191-199.
7. Dazzan P, et al: The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain 2004; 127:143-153.
8. Marcus J, et al: Neurological findings in high-risk children: childhood assessment and 5-year follow-up. Schizophr Bull 1985; 11:85-100.
9. Lawrie SM, et al: Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia. Br J Psychiatry 2001; 178:524-530.
10. Biswas P, et al: Comparative study of neurological soft signs in schizophrenia with onset in childhood, adolescence and adulthood. Acta Psychiatr Scand 2007; 115:295-303.
11. Janssen J, et al: Brain morphology and neurological soft signs in adolescents with first-episode psychosis. Br J Psychiatry 2009; 195:227-233.
12. Thomann PA, et al: Neurological soft signs and brain morphology in first-episode schizophrenia. Psychol Med 2009; 39:371-379.
13. Hirjak D, et al: Neurological soft signs and subcortical brain morphology in recent onset schizophrenia. J Psychiatr Res 2012; 46:533-539.
14. Venkatasubramanian G, et al: Neuroanatomi-cal correlates of neurological soft signs in anti-psychotic-naive schizophrenia. Psychiatry Res 2008; 164: 215-222.
15. Mouchet-Mages S, et al: Correlations of cere-bello-thalamo-prefrontal structure and neurological soft signs in patients with first-episode psychosis. Acta Psychiatr Scand 2011; 123:451-458.
16. Thomann PA, et al: Cerebellar substructures and neurological soft signs in first-episode schizophrenia. Psychiatry Res 2009; 173:83-87.
17. Bersani G, et al: Neurological soft signs and corpus callosum morphology in schizophrenia. Neurosci Lett 2011; 499:170-174.
18. Schroder J, et al: Sensorimotor cortex and supplementary motor area changes in schizophrenia. A study with functional magnetic resonance imaging. Br J Psychiatry 1995; 167: 197-201.
19. Schroder J, et al: Motor dysfunction and sen-sorimotor cortex activation changes in schizophrenia: a study with functional magnetic resonance imaging. Neuroimage 1999; 9: 81-87.
20. Andreasen NC, Paradiso S, O'Leary DS: 'Cognitive dysmetria' as an integrative theory of schizophrenia: a dysfunction in cortical-sub-cortical- cerebellar circuitry? Schizophr Bull 1998; 24:203-218.
21. Sasaki M, et al: Monoamine neurons in the human brain stem: anatomy, magnetic resonance imaging findings, and clinical implications. Neuroreport 2008; 19:1649-1654.
22. Grinberg LT, Rueb U, Heinsen H: Brainstem: neglected locus in neurodegenerative diseases. Front Neurol 2011; 2:42.
23. Tzschentke TM: Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog Neurobiol 2001; 63: 241-320.
24. Nishio Y, et al: Frontal-lobe syndrome and psychosis after damage to the brainstem dopa-minergic nuclei. J Neurol Sci 2007; 260:271-274.
25. Feinberg WM, Rapcsak SZ: 'Peduncular hallucinosis' following paramedian thalamic infarction. Neurology 1989; 39:1535-1536.
26. Murray GK, et al: Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Mol Psychiatry 2008; 13:239, 267-276.
27. Bogerts B, Hantsch J, Herzer M: A morpho-metric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics. Biol Psychiatry 1983; 18:951-969.
28. Shibata E, et al: Use of neuromelanin-sensitive MRI to distinguish schizophrenic and depressive patients and healthy individuals based on signal alterations in the substantia nigra and locus ceruleus. Biol Psychiatry 2008; 64: 401-406.
29. Heuser M, et al: Neurological signs and morphological cerebral changes in schizophrenia: an analysis of NSS subscales in patients with first episode psychosis. Psychiatry Res 2011; 192:69-76.
30. Weinberger DR: Computed tomography (CT) findings in schizophrenia: speculation on the meaning of it all. J Psychiatr Res 1984; 18:477-490.
31. Raz S, Raz N: Structural brain abnormalities in the major psychoses: a quantitative review of the evidence from computerized imaging. Psychol Bull 1990; 108:93-108.
32. Fisman M: The brain stem in psychosis. Br J Psychiatry 1975; 126:414-422.
33. Patenaude B, et al: A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011; 56:907-922.
34. Woods SW: Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003; 64:663-667.
35. Schroder J, et al: Neurological soft signs in schizophrenia. Schizophr Res 1991; 6:25-30.
36. Bachmann S, Bottmer C, Schroder J: Neurological soft signs in first-episode schizophrenia: a follow-up study. Am J Psychiatry 2005; 162:2337-2343.
37. Wittchen HU, et al: SKID-I: Strukturiertes klinisches Interview für DSM-IV. Göttingen, Hogrefe, 1997.
38. Oldfield RC: The assessment and analysis of handedness: the Edinburgh inventory. Neu-ropsychologia 1971; 9:97-113.
39. Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10:799-812.
40. Andreasen NC: The Scale for the Assessment of Positive Symptoms (SAPS). Iowa, University of Iowa, 1984.
41. Andreasen NC: The Scale for the Assessment of Negative Symptoms (SANS). Iowa, University of Iowa, 1983.
42. Strauss JS, Carpenter WT Jr: The prediction of outcome in schizophrenia. II. Relationships between predictor and outcome variables: a report from the WHO international pilot study of schizophrenia. Arch Gen Psychiatry 1974; 31:37-42.
43. Patenaude B: Bayesian Statistical Models of Shape and Appearance for Subcortical Brain Segmentation. Oxford, University of Oxford, 2007.
44. Genovese CR, Lazar NA, Nichols T: Thresholding of statistical maps in functional neuro-imaging using the false discovery rate. Neuroimage 2002; 15:870-878.
45. Cadet JL: A unifying theory of movement and madness: involvement of free radicals in disorders of the isodendritic core of the brain-stem. Med Hypotheses 1988; 27:59-63.
46. Shapiro RM: Regional neuropathology in schizophrenia: where are we? Where are we going? Schizophr Res 1993; 10: 187-239.
47. Davison K, Bagley CR: Schizophrenia-like psychoses associated with organic disorders of the central nervous system: a review of literature. Br J Psychiatry 1969;4(spec issue):113-184.
48. Nopoulos PC, et al: An MRI study of mid-brain morphology in patients with schizophrenia: relationship to psychosis, neurolep-tics, and cerebellar neural circuitry. Biol Psychiatry 2001; 49:13-19.
49. Aylward EH, et al: Magnetic resonance imaging measurement of posterior fossa structures in schizophrenia. Am J Psychiatry 1994; 151: 1448-1452.
50. Minabe Y, Kadono Y, Kurachi M: A schizophrenic syndrome associated with a midbrain tegmental lesion. Biol Psychiatry 1990; 27:661-663.
51. Scherk H, Falkai P: Effects of antipsychotics on brain structure. Curr Opin Psychiatry 2006; 19: 145-150.
52. Yoshihara Y, et al: Voxel-based structural magnetic resonance imaging (MRI) study of patients with early onset schizophrenia. Ann Gen Psychiatry 2008; 7: 25.
53. Douaud G, et al: Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. Brain 2007; 130:2375-2386.
54. Kyriakopoulos M, Frangou S: Recent diffusion tensor imaging findings in early stages of schizophrenia. Curr Opin Psychiatry 2009; 22: 168-176.
55. 2/3 receptor binding in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2006; 256:382-387.
56. Wolf RC, et al: Temporally anticorrelated brain networks during working memory performance reveal aberrant prefrontal and hippo-campal connectivity in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33:1464-1473.
57. Walter H, et al: Dysfunction of the social brain in schizophrenia is modulated by intention type: an fMRI study. Soc Cogn Affect Neurosci 2009; 4:166-176.
58. Bottmer C, et al: Reduced cerebellar volume and neurological soft signs in first-episode schizophrenia. Psychiatry Res 2005; 140:239-250.
59. 123I-io-dobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatment. Biol Psychiatry 1998; 43:660-665.
60. Howes OD, et al: Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis. Br J Psychiatry Suppl 2007; 51: 13-18.
61. Whitford TJ, et al: Schizophrenia, myelina-tion, and delayed corollary discharges: a hypothesis. Schizophr Bull 2012, 38: 486-494.
62. Kong L, et al: Reduced gray to white matter tissue intensity contrast in schizophrenia. PLoS One 2012; 7:e37016.
63. Prasad KM, et al: Cortical surface characteristics among offspring of schizophrenia subjects. Schizophr Res 2010; 116:143-151.
64. Neelam K, Garg D, Marshall M: A systematic review and meta-analysis of neurological soft signs in relatives of people with schizophrenia. BMC Psychiatry 2011; 11:139.
65. Kong L, et al: Neurological soft signs and gray matter changes: a longitudinal analysis in firstepisode schizophrenia. Schizophr Res 2012; 134: 27-32.
66. Gay O, et al: Cortex morphology in first-episode psychosis patients with neurological soft signs. Schizophr Bull, E-pub ahead of print.
67. Heinrichs DW, Buchanan RW: Significance and meaning of neurological signs in schizophrenia. Am J Psychiatry 1988; 145:11-18.
68. Marcus J, et al: Neurological dysfunctioning in offspring of schizophrenics in Israel and Denmark. A replication analysis. Arch Gen Psychiatry 1985; 42:753-761.
69. Ridler K, et al: Fronto-cerebellar systems are associated with infant motor and adult executive functions in healthy adults but not in schizophrenia. Proc Natl Acad Sci USA 2006; 103:15651-15656.
70. Pantelis C, et al: Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003; 361:281-288.
71. Walther S, et al: Quantitative motor activity differentiates schizophrenia subtypes. Neuro-psychobiology 2009; 60:80-86.
72. Shenton ME, Whitford TJ, Kubicki M: Structural neuroimaging in schizophrenia: from methods to insights to treatments. Dialogues Clin Neurosci 2010; 12:317-332.